Company Overview
Snapshot
Founded in March 2017 by Rony Oren Benaroya and Amir Ayali, IBI-Ag operates with 11–50 employees. The company has raised $11.64M across 7 funding rounds from 9 investors. In November 2025, IBI-Ag completed a Series A round led by Corteva.
Business overview
IBI-Ag is an Israeli startup focused on developing biological solutions for insect control within the agriculture and food technologies sector. The company leverages breakthrough technology to produce efficient, selective, and safe bio-insecticides, aiming to provide environmentally friendly alternatives to traditional pesticides. Its core technology is designed for cost-effective fermentation, enabling farmers to produce agricultural produce at a lower cost. IBI-Ag serves the global agricultural market, contributing to sustainable farming practices and plant protection.
Strategic signal
In November 2025, IBI-Ag successfully closed a Series A funding round, led by Corteva, a significant player in the agricultural sector. This investment highlights strong market validation for IBI-Ag's bio-insecticide technology and signals growing investor confidence in sustainable crop protection solutions. It positions the company for accelerated development and commercialization of its environmentally friendly products, indicating a positive trajectory for addressing the global demand for sustainable agriculture.
Log in to access full profile ›Company Intelligence Q&A
- Who are the founders of IBI-Ag?
- IBI-Ag was co-founded by Rony Oren Benaroya, who serves as CTO, and Amir Ayali, who is a Scientific Advisor.
- What is IBI-Ag's core technology?
- IBI-Ag utilizes breakthrough technology to produce efficient, selective, and safe biological insect-control solutions that are cost-effective due to their fermentation suitability.
- Which investors participated in IBI-Ag's June 2021 funding round?
- In June 2021, IBI-Ag completed a funding round with participation from Bayer Trendlines Ag Innovation Fund.